Disruptions in β-cell function and glucose homeostasis are well-established physiologic hallmarks of human diabetes. Whilst insulin supplements can be used to maintain blood glucose, insulin-resistance is increasing among diabetes patients. In order to develop more durable and less invasive disease-modifying therapies an improved molecular-level understanding of β-cell function is necessary.
Dr Jarrod Marto’s lab from the Dana-Farber Cancer Institute recently published a paper in Nature Metabolism on a multi-omic approach used to characterize primary insulin-secreting pancreatic β-cells using the timsTOF Pro - details of which are described in this app note.
Download this app note to discover how to: